Norway Veterinary Dermatology Drugs Market Size & Outlook
Related Markets
Norway veterinary dermatology drugs market highlights
- The Norway veterinary dermatology drugs market generated a revenue of USD 159.0 millions in 2024 and is expected to reach USD 279.8 millions by 2030.
- The Norway market is expected to grow at a CAGR of 10.2% from 2025 to 2030.
- In terms of segment, parasitic infections was the largest revenue generating indication in 2024.
- Allergic Infections is the most lucrative indication segment registering the fastest growth during the forecast period.
Veterinary dermatology drugs market data book summary
| Market revenue in 2024 | USD 159.0 millions |
| Market revenue in 2030 | USD 279.8 millions |
| Growth rate | 10.2% (CAGR from 2025 to 2030) |
| Largest segment | Parasitic infections |
| Fastest growing segment | Allergic Infections |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD millions |
| Market segmentation | Parasitic Infections, Allergic Infections |
| Key market players worldwide | Elanco Animal Health Inc, CEVA Inc, Vetoquinol SA, Merck & Co Inc, Zoetis Inc Class A, Virbac SA, Bimeda, Bioiberica, Boehringer Ingelheim Pharma |
Other key industry trends
- In terms of revenue, Norway accounted for 0.9% of the global veterinary dermatology drugs market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, UK veterinary dermatology drugs market is projected to lead the regional market in terms of revenue in 2030.
- Germany is the fastest growing regional market in Europe and is projected to reach USD 2,036.7 millions by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Veterinary Dermatology Drugs Market Scope
Veterinary Dermatology Drugs Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Bioiberica | View profile | 251-500 | Barcelona, Catalonia, Spain, Europe | https://www.bioiberica.com/ |
| Bimeda | View profile | 1001-5000 | Dublin, Dublin, Ireland, Europe | https://www.bimeda.com/ |
| Boehringer Ingelheim Pharma | View profile | 10001+ | Dortmund, Nordrhein-Westfalen, Germany, Europe | https://www.boehringer-ingelheim.de/unternehmensprofil/unser-unternehmen/standort-dortmund |
| Vetoquinol SA | View profile | 2483 | Magny-Vernois, BP 189, Lure cedex, France, 70204 | http://www.vetoquinol.com |
| Elanco Animal Health Inc | View profile | 9800 | 2500 Innovation Way, Greenfield, IN, United States, 46140 | https://www.elanco.com |
| Merck & Co Inc | View profile | 72000 | 126 East Lincoln Avenue, Rahway, NJ, United States, 07065 | https://www.merck.com |
| CEVA Inc | View profile | 424 | 15245 Shady Grove Road, Suite 400, Rockville, MD, United States, 20850 | https://www.ceva-dsp.com |
| Virbac SA | View profile | 5400 | 2065m LID, 1 ere avenue, Carros, France, 06516 | https://www.virbac.com |
| Zoetis Inc Class A | View profile | 14100 | 10 Sylvan Way, Parsippany, NJ, United States, 07054 | https://www.zoetis.com |
Norway veterinary dermatology drugs market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to veterinary dermatology drugs market will help companies and investors design strategic landscapes.
Parasitic infections was the largest segment with a revenue share of 45.09% in 2024. Horizon Databook has segmented the Norway veterinary dermatology drugs market based on parasitic infections, allergic infections covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to Norway veterinary dermatology drugs market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Norway veterinary dermatology drugs market databook
-
Our clientele includes a mix of veterinary dermatology drugs market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Norway veterinary dermatology drugs market, including forecasts for subscribers. This country databook contains high-level insights into Norway veterinary dermatology drugs market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Norway veterinary dermatology drugs market report size, by indication, 2018-2030 (US$Ms)
Norway Veterinary Dermatology Drugs Market Share, 2024 & 2030 (US$Ms)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
